Gu H, Wang L, Zhang Y, Zhuo Y, Zhang Z, Wei X
    
    
    Cell Mol Biol Lett. 2025; 30(1):21.
  
  
    PMID: 39972244
    
          PMC: 11840982.
    
          DOI: 10.1186/s11658-025-00701-1.
      
 
                                  
  
    Soleimany Z, Siadat F, Farhadi M, Mirshaby Z, Sanadgol Z, Eyni H
    
    
    JBRA Assist Reprod. 2025; 29(1):117-126.
  
  
    PMID: 39835794
    
          PMC: 11867258.
    
          DOI: 10.5935/1518-0557.20240101.
      
 
                                  
  
    Qu Q, Liu L, Wang L, Cui Y, Liu C, Jing X
    
    
    Stem Cell Res Ther. 2024; 15(1):496.
  
  
    PMID: 39709481
    
          PMC: 11663355.
    
          DOI: 10.1186/s13287-024-04111-6.
      
 
                                  
  
    Wang J, Zhen C, Zhang G, Yang Z, Shang P
    
    
    Int J Mol Sci. 2024; 25(23).
  
  
    PMID: 39684847
    
          PMC: 11642155.
    
          DOI: 10.3390/ijms252313136.
      
 
                                  
  
    Yan L, Tu W, Zhao X, Wan H, Wu J, Zhao Y
    
    
    Cell Discov. 2024; 10(1):111.
  
  
    PMID: 39496598
    
          PMC: 11535534.
    
          DOI: 10.1038/s41421-024-00726-4.
      
 
                              
              
                              
                                      
  Engineering mesenchymal stem cells for premature ovarian failure: overcoming challenges and innovating therapeutic strategies.
  
    Yuan Z, Zhang Y, He X, Wang X, Wang X, Ren S
    
    
    Theranostics. 2024; 14(17):6487-6515.
  
  
    PMID: 39479455
    
          PMC: 11519806.
    
          DOI: 10.7150/thno.102641.
      
 
                                          
                                                          
  Bone marrow mesenchymal stem cells expressing Neat-1, Hotair-1, miR-21, miR-644, and miR-144 subsided cyclophosphamide-induced ovarian insufficiency by remodeling the IGF-1-kisspeptin system, ovarian apoptosis, and angiogenesis.
  
    Ahmed A, Dowidar M, Negm A, Abdellatif H, Alanazi A, Alassiri M
    
    
    J Ovarian Res. 2024; 17(1):184.
  
  
    PMID: 39267091
    
          PMC: 11396253.
    
          DOI: 10.1186/s13048-024-01498-x.
      
 
                                          
                                                          
  Ameliorative effects of mesenchymal stromal cells on senescence associated phenotypes in naturally aged rats.
  
    Wang L, Deng Z, Li Y, Wu Y, Yao R, Cao Y
    
    
    J Transl Med. 2024; 22(1):722.
  
  
    PMID: 39103873
    
          PMC: 11302158.
    
          DOI: 10.1186/s12967-024-05486-z.
      
 
                                          
                                                          
  Investigating the potential role of α-SNAP in preventing chemotherapy-induced ovarian dysfunction: Insights from cellular and animal models.
  
    Qin Y, Wen C, Hu B, Wu H
    
    
    Heliyon. 2024; 10(12):e32802.
  
  
    PMID: 38994045
    
          PMC: 11237948.
    
          DOI: 10.1016/j.heliyon.2024.e32802.
      
 
                                          
                                                          
  Preservation of ovarian function using human pluripotent stem cell-derived mesenchymal progenitor cells.
  
    Lee D, Lee J
    
    
    Clin Exp Reprod Med. 2024; 52(1):30-37.
  
  
    PMID: 38782038
    
          PMC: 11900672.
    
          DOI: 10.5653/cerm.2024.07003.
      
 
                                          
                                                          
  Effect of Intra-ovarian Injection of Mesenchymal Stem Cells or its Conditioned Media on Repeated OPU-IVEP Outcomes in Jersey Heifers and Its Relationship with Follicular Fluid Inflammatory Markers.
  
    Sarvari A, Niasari-Naslaji A, Shirazi A, Heidari B, Borjian Boroujeni S, Moradi M
    
    
    Avicenna J Med Biotechnol. 2024; 16(1):16-28.
  
  
    PMID: 38605741
    
          PMC: 11005394.
    
          DOI: 10.18502/ajmb.v16i1.14167.
      
 
                                          
                                                          
  The remodeling of ovarian function: targeted delivery strategies for mesenchymal stem cells and their derived extracellular vesicles.
  
    Song Y, Wu J, Liu Y, Xu N, Bai H, Wang L
    
    
    Stem Cell Res Ther. 2024; 15(1):90.
  
  
    PMID: 38539206
    
          PMC: 10976842.
    
          DOI: 10.1186/s13287-024-03704-5.
      
 
                                          
                                                          
  Protective role of stem cells in POI: Current status and mechanism of action, a review article.
  
    Sadeghi S, Mosaffa N, Huang B, Ramezani Tehrani F
    
    
    Heliyon. 2024; 10(1):e23271.
  
  
    PMID: 38169739
    
          PMC: 10758796.
    
          DOI: 10.1016/j.heliyon.2023.e23271.
      
 
                                          
                                                          
  Tissue engineering and stem cell-based therapeutic strategies for premature ovarian insufficiency.
  
    Kuchakzadeh F, Ai J, Ebrahimi-Barough S
    
    
    Regen Ther. 2023; 25:10-23.
  
  
    PMID: 38108045
    
          PMC: 10724490.
    
          DOI: 10.1016/j.reth.2023.11.007.
      
 
                                          
                                                          
  Research Progress on the Etiology and Treatment of Premature Ovarian Insufficiency.
  
    Wang Y, Jiang J, Zhang J, Fan P, Xu J
    
    
    Biomed Hub. 2023; 8(1):97-107.
  
  
    PMID: 38094192
    
          PMC: 10718577.
    
          DOI: 10.1159/000535508.
      
 
                                          
                                                          
  Comparison the therapeutic effects of bone marrow CD144 endothelial cells and CD146 mesenchymal stem cells in POF rats.
  
    Yamchi N, Amjadi F, Beheshti R, Hassanpour M, Shirazi R, Tamadon A
    
    
    Bioimpacts. 2023; 13(6):495-504.
  
  
    PMID: 38022384
    
          PMC: 10676523.
    
          DOI: 10.34172/bi.2023.27781.
      
 
                                          
                                                          
  The effects of intraovarian injection of autologous menstrual blood-derived mesenchymal stromal cells on pregnancy outcomes in women with poor ovarian response.
  
    Zafardoust S, Kazemnejad S, Fathi-Kazerooni M, Darzi M, Sadeghi M, Sadeghi Tabar A
    
    
    Stem Cell Res Ther. 2023; 14(1):332.
  
  
    PMID: 37968668
    
          PMC: 10647057.
    
          DOI: 10.1186/s13287-023-03568-1.
      
 
                                          
                                                          
  Application of mesenchymal stem cells for anti-senescence and clinical challenges.
  
    Wang Y, Gao T, Wang B
    
    
    Stem Cell Res Ther. 2023; 14(1):260.
  
  
    PMID: 37726805
    
          PMC: 10510299.
    
          DOI: 10.1186/s13287-023-03497-z.
      
 
                                          
                                                          
  Human umbilical cord mesenchymal stem cells (hUC-MSCs) alleviate paclitaxel-induced spermatogenesis defects and maintain male fertility.
  
    Zhang Y, Liu Y, Teng Z, Wang Z, Zhu P, Wang Z
    
    
    Biol Res. 2023; 56(1):47.
  
  
    PMID: 37574561
    
          PMC: 10424423.
    
          DOI: 10.1186/s40659-023-00459-w.
      
 
                                          
                                                          
  Hypothalamic-Pituitary-Gonadal Axis Disorders Impacting Fertility in Both Sexes and the Potential of Kisspeptin-Based Therapies to Treat Them.
  
    Acosta-Martinez M
    
    
    Handb Exp Pharmacol. 2023; 282:259-288.
  
  
    PMID: 37439848
    
    
          DOI: 10.1007/164_2023_666.